USA

Piper Sandler Maintains DENTSPLY Sirona (XRAY) Neutral Recommendation

Fintel reports that on September 22, 2023, Piper Sandler maintained coverage of DENTSPLY Sirona (NASDAQ:XRAY) with a Neutral recommendation.

Analyst Price Forecast Suggests 34.37% Upside

As of August 31, 2023, the average one-year price target for DENTSPLY Sirona is 45.90. The forecasts range from a low of 41.41 to a high of $53.55. The average price target represents an increase of 34.37% from its latest reported closing price of 34.16.

See our leaderboard of companies with the largest price target upside.

The projected annual revenue for DENTSPLY Sirona is 3,871MM, a decrease of 1.65%. The projected annual non-GAAP EPS is 1.90.

What is the Fund Sentiment?

There are 1035 funds or institutions reporting positions in DENTSPLY Sirona. This is a decrease of 35 owner(s) or 3.27% in the last quarter. Average portfolio weight of all funds dedicated to XRAY is 0.18%, a decrease of 6.09%. Total shares owned by institutions decreased in the last three months by 4.29% to 244,186K shares. The put/call ratio of XRAY is 0.23, indicating a bullish outlook.

What are Other Shareholders Doing?

XRAY / DENTSPLY Sirona Inc Shares Held by Institutions

Artisan Partners Limited Partnership holds 13,474K shares representing 6.36% ownership of the company. In it’s prior filing, the firm reported owning 13,732K shares, representing a decrease of 1.91%. The firm decreased its portfolio allocation in XRAY by 2.26% over the last quarter.

First Eagle Investment Management holds 9,736K shares representing 4.60% ownership of the company. In it’s prior filing, the firm reported owning 9,755K shares, representing a decrease of 0.19%. The firm decreased its portfolio allocation in XRAY by 1.15% over the last quarter.

Nuance Investments holds 9,015K shares representing 4.26% ownership of the company. In it’s prior filing, the firm reported owning 10,962K shares, representing a decrease of 21.59%. The firm decreased its portfolio allocation in XRAY by 15.45% over the last quarter.

Janus Henderson Group holds 7,724K shares representing 3.65% ownership of the company. In it’s prior filing, the firm reported owning 7,705K shares, representing an increase of 0.25%. The firm decreased its portfolio allocation in XRAY by 4.89% over the last quarter.

Price T Rowe Associates holds 7,018K shares representing 3.31% ownership of the company. In it’s prior filing, the firm reported owning 7,802K shares, representing a decrease of 11.17%. The firm increased its portfolio allocation in XRAY by 92.46% over the last quarter.

DENTSPLY Sirona Background Information
(This description is provided by the company.)

Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.

Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.

Click to Learn More

This story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Summarize this content to 100 words

Fintel reports that on September 22, 2023, Piper Sandler maintained coverage of DENTSPLY Sirona (NASDAQ:XRAY) with a Neutral recommendation. Analyst Price Forecast Suggests 34.37% Upside As of August 31, 2023, the average one-year price target for DENTSPLY Sirona is 45.90. The forecasts range from a low of 41.41 to a high of $53.55. The average price target represents an increase of 34.37% from its latest reported closing price of 34.16.

See our leaderboard of companies with the largest price target upside. The projected annual revenue for DENTSPLY Sirona is 3,871MM, a decrease of 1.65%. The projected annual non-GAAP EPS is 1.90. What is the Fund Sentiment? There are 1035 funds or institutions reporting positions in DENTSPLY Sirona. This is a decrease of 35 owner(s) or 3.27% in the last quarter. Average portfolio weight of all funds dedicated to XRAY is 0.18%, a decrease of 6.09%. Total shares owned by institutions decreased in the last three months by 4.29% to 244,186K shares. The put/call ratio of XRAY is 0.23, indicating a bullish outlook. What are Other Shareholders Doing? Artisan Partners Limited Partnership holds 13,474K shares representing 6.36% ownership of the company. In it’s prior filing, the firm reported owning 13,732K shares, representing a decrease of 1.91%. The firm decreased its portfolio allocation in XRAY by 2.26% over the last quarter. First Eagle Investment Management holds 9,736K shares representing 4.60% ownership of the company. In it’s prior filing, the firm reported owning 9,755K shares, representing a decrease of 0.19%. The firm decreased its portfolio allocation in XRAY by 1.15% over the last quarter.

Nuance Investments holds 9,015K shares representing 4.26% ownership of the company. In it’s prior filing, the firm reported owning 10,962K shares, representing a decrease of 21.59%. The firm decreased its portfolio allocation in XRAY by 15.45% over the last quarter. Janus Henderson Group holds 7,724K shares representing 3.65% ownership of the company. In it’s prior filing, the firm reported owning 7,705K shares, representing an increase of 0.25%. The firm decreased its portfolio allocation in XRAY by 4.89% over the last quarter. Price T Rowe Associates holds 7,018K shares representing 3.31% ownership of the company. In it’s prior filing, the firm reported owning 7,802K shares, representing a decrease of 11.17%. The firm increased its portfolio allocation in XRAY by 92.46% over the last quarter. DENTSPLY Sirona Background Information(This description is provided by the company.) Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry.

Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
Click to Learn MoreThis story originally appeared on Fintel.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

https://www.nasdaq.com/articles/piper-sandler-maintains-dentsply-sirona-xray-neutral-recommendation Piper Sandler Maintains DENTSPLY Sirona (XRAY) Neutral Recommendation

Back to top button